Steven Cohen’s Organogenesis Holdings ORGO Stock Holding History

Steven Cohen’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,000	Closed	-$143K	–	2641
2023 Q3	$143K	Buy	+45,000	New	+$143K	﹤0.01%	1860

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Steven Cohen's ORGO Position: Q2 2026 in Review

Steven Cohen sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 148,358 shares — an estimated $352K sold.

Steven Cohen first reported a position in ORGO in Q1 2023 and held it in 5 quarters. The position peaked at $2.02M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Steven Cohen reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 148,358 Organogenesis Holdings shares in Q2 2026, an estimated $352K.
Steven Cohen first reported a position in Organogenesis Holdings in Q1 2023 and held it in 5 quarters.
Steven Cohen's Organogenesis Holdings position peaked at $2.02M in Q4 2025.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.